Michael and Robin Camerer | camererforillinois.com
Michael and Robin Camerer | camererforillinois.com
Dr. Michael Camerer advanced in the Illinois primary as the Republican candidate to represent District 45 in the Illinois House of Representatives.
Camerer won the March 17 election, with 2,307 votes. Challengers Harry R. Ramey, Jr., and Alfredo Manzo received 1,973 votes and 538 votes, respectively.
Ramey represented the 55th District from 2005 to 2012, and currently represents the 95th district. He is a member of the Consumer Protection Committee, the State Government Administration Committee, the Committee on Aging, Telecommunications and several others.
Camerer has served as a trustee in Bartlett Village since 2013 and remains active in the Bartlett Rotary Club and Chamber of Commerce. He has also been involved in a variety of other community organizations, including the Bartlett Learning Center/Clare Woods Academy, Veterans Memorial Foundation and others. He currently teaches as an adjunct professor at Judson University, in Elgin, in addition to his chiropractic practice.
He earned a Doctorate in Chiropractic Medicine in 1984 from National College of Chiropractic in Lombard, IL, and opened the Camerer Chiropractic Clinic in Bartlett in 1990. He also earned a Bachelor of Arts in Science from Judson University, and a masters degree in anatomy and physiology instruction.
Camerer's platform includes consolidating governmental agencies, reducing income and property taxes, and creating ethics legislation, as well as penalties for public corruption and term limits. He was endorsed by the Examiner and Chicago Tribune in the primary election.
Camerer will now face incumbent Democrat Diane Pappas in the November general election.
Pappas defeated challenger Christine Winger (R) in the 2018 general election. As a state representative, Pappas has been assigned to the Appropriations-General Service Committee, Cybersecurity, Data Analytics and IT Committee, Cities and Villages Committee, Adoption and Child Welfare Committee and the Prescription Drug Affordability Committee.